- Home
- NXPL vs TENX Comparison
NXPL vs TENX Comparison
Compare NXPL & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- TENX
- Stock Information
- Founded
- NXPL 1997
- TENX 1967
- Country
- NXPL United States
- TENX United States
- Employees
- NXPL N/A
- TENX N/A
- Industry
- NXPL Telecommunications Equipment
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- NXPL Telecommunications
- TENX Health Care
- Exchange
- NXPL Nasdaq
- TENX Nasdaq
- Market Cap
- NXPL 22.8M
- TENX 27.3M
- IPO Year
- NXPL N/A
- TENX N/A
- Fundamental
- Price
- NXPL $0.81
- TENX $7.51
- Analyst Decision
- NXPL
- TENX Strong Buy
- Analyst Count
- NXPL 0
- TENX 4
- Target Price
- NXPL N/A
- TENX $16.67
- AVG Volume (30 Days)
- NXPL 282.9K
- TENX 128.9K
- Earning Date
- NXPL 11-13-2025
- TENX 11-12-2025
- Dividend Yield
- NXPL N/A
- TENX N/A
- EPS Growth
- NXPL N/A
- TENX N/A
- EPS
- NXPL N/A
- TENX N/A
- Revenue
- NXPL $58,766,000.00
- TENX N/A
- Revenue This Year
- NXPL N/A
- TENX N/A
- Revenue Next Year
- NXPL N/A
- TENX N/A
- P/E Ratio
- NXPL N/A
- TENX N/A
- Revenue Growth
- NXPL N/A
- TENX N/A
- 52 Week Low
- NXPL $0.43
- TENX $3.25
- 52 Week High
- NXPL $2.30
- TENX $7.91
- Technical
- Relative Strength Index (RSI)
- NXPL 50.40
- TENX 76.59
- Support Level
- NXPL $0.77
- TENX $7.45
- Resistance Level
- NXPL $0.86
- TENX $7.91
- Average True Range (ATR)
- NXPL 0.06
- TENX 0.32
- MACD
- NXPL -0.00
- TENX 0.08
- Stochastic Oscillator
- NXPL 15.89
- TENX 79.60
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.